jonboixxx
Active Member
- Joined
- Jan 2, 2014
- Posts
- 607
- Qantas
- Platinum
- Virgin
- Platinum
- Star Alliance
- Gold
You stated "start to finish" and have disparaged CSL and alluded to actions by CSL, that you have in no way proven. Your grandiose "spoilers" are nothing but an inexplicable campaign against CSL.From the date of physical posession being granted to the first manufacturing was from December 2020 to 10 Feb 2021 media release announcing commencing manufacturing (link from BioNTech previously provided). Just under 3 months.
It does not say that.In the immediately following lines (of the post you refer to) there is an article that mentions 'CSL owns the site' that BioNTech has acquired the space in. Also that it is very fast to set-up the equipment.
NO, they don't!!!!!So CSL owns the Behringwerke facility of which a component was under a long term lease to Novartis and this long term lease(d space) was subsequently sold to BioNTech - agreed?
You quote;
"More than 5,000 visitors recently took the opportunity to look behind the scenes of CSL Behring's leading-edge operation in Marburg, Germany, at an open house event for multiple businesses based at the site called “Behringwerke.”"
It seems you are being either obtuse or misleading, as you have obstinately refused to acknowledged obvious information.
Behringwerke is a magnificent facility that encompasses numerous facilities that ARE NOT OWNED BY CSL. Anyone interested can read below.
Home | Behringwerke
Standort Behringwerke Marburg ist ein Biotech-Center mit innovativen Pharma-Unternehmen und somit kein „klassischer Chemiepark“. Pharmaserv, der auf Biotechnologie und Pharmaproduktion spezialisierte Standortbetreiber, betreut die angesiedelten Unternehmen.
www.behringwerke.com